Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Refractory Burkitt Lymphoma Responding to an Accelerated Ramp-up of Glofitamab With Polatuzumab.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 02, 2026
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.
Journal: British journal of haematology
Published: February 24, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.
Journal: Cancer research communications
Published: February 17, 2025
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Journal: The New England journal of medicine
Published: July 24, 2024
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: September 04, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.
Journal: Cancer medicine
Published: August 08, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.
Journal: Blood advances
Published: April 18, 2023
Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy.
Journal: Journal of adolescent and young adult oncology
Published: November 11, 2022
Last Updated: 09/26/2026